ASC36 once a month.
-
"ASC36 is a synthetic peptide. Developed by Ascletis Pharma, it acts as an amylin receptor agonist and is being studied as a long-acting treatment for obesity and metabolic diseases." Anyone?
-
Looks pretty wild. Atleast its something different. Instead of another name for a mix of glp and gip agonists people will add to their other glp agonist stacks. Lol
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Register Login